Bao Yi, Yang Yuan, Wang Li, Gao Lei, Jiang Wei, Wang Lifei, Si Shuyi, Hong Bin
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
Atherosclerosis. 2009 May;204(1):127-35. doi: 10.1016/j.atherosclerosis.2008.08.041. Epub 2008 Sep 11.
Scavenger receptor class B type I (SR-BI) and its human homologue CLA-1 plays an important role in reverse cholesterol transport (RCT). Using a previously established cell-based CLA-1 up-regulator screening assay, one of the positive strains, 04-9179, presented potent activity in elevating CLA-1 transcriptional level. We report here the identification of an active compound 9179A as a known compound trichostatin A (TSA), and its effects on CLA-1/SR-BI expression both in HepG2 human hepatoma cells and RAW 264.7 murine macrophage cells in vitro. The results showed that the mRNA and protein level of CLA-1/SR-BI were significantly up-regulated by 9179A both in HepG2 and RAW 264.7 cells. Corresponding to this, the uptake of DiI-HDL by both cells and the efflux of [(3)H]cholesterol by RAW 264.7 cells were increased by 9179A in dose-dependent manner. ABCA1 was also increased but SR-A decreased by 9179A in RAW 264.7 cells. Using a combination of reporter assays with various deletion in CLA-1 promoter and electrophoretic mobility shift assay, we demonstrated that -419/-232 bp fragment of the CLA-1 promoter mediated the effects of 9179A (i.e., TSA). Together, these studies identified TSA as a novel up-regulator of CLA-1/SR-BI both in HepG2 and RAW 264.7 cells.
I型清道夫受体B类(SR-BI)及其人类同源物CLA-1在胆固醇逆向转运(RCT)中起重要作用。利用先前建立的基于细胞的CLA-1上调调节剂筛选试验,其中一个阳性菌株04-9179在提高CLA-1转录水平方面表现出强大的活性。我们在此报告一种活性化合物9179A的鉴定,它是一种已知化合物曲古抑菌素A(TSA),以及它在体外对HepG2人肝癌细胞和RAW 264.7小鼠巨噬细胞中CLA-1/SR-BI表达的影响。结果表明,9179A在HepG2和RAW 264.7细胞中均显著上调了CLA-1/SR-BI的mRNA和蛋白质水平。与此相应,9179A以剂量依赖方式增加了两种细胞对DiI-HDL的摄取以及RAW 264.7细胞中[(3)H]胆固醇的流出。在RAW 264.7细胞中,9179A还增加了ABCA1但降低了SR-A。通过结合使用CLA-1启动子各种缺失的报告基因分析和电泳迁移率变动分析,我们证明CLA-1启动子的-419/-232 bp片段介导了9179A(即TSA)的作用。总之,这些研究确定TSA是HepG2和RAW 264.7细胞中CLA-1/SR-BI的新型上调调节剂。